EQUILLIUM INC (EQ) Fundamental Analysis & Valuation

NASDAQ:EQ • US29446K1060

Current stock price

1.95 USD
-0.1 (-4.88%)
Last:

This EQ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. EQ Profitability Analysis

1.1 Basic Checks

  • EQ had negative earnings in the past year.
  • In the past year EQ has reported a negative cash flow from operations.
  • EQ had negative earnings in each of the past 5 years.
  • EQ had a negative operating cash flow in each of the past 5 years.
EQ Yearly Net Income VS EBIT VS OCF VS FCFEQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M

1.2 Ratios

  • EQ has a Return On Assets of -70.24%. This is in the lower half of the industry: EQ underperforms 65.31% of its industry peers.
  • EQ has a Return On Equity of -78.32%. This is comparable to the rest of the industry: EQ outperforms 48.84% of its industry peers.
Industry RankSector Rank
ROA -70.24%
ROE -78.32%
ROIC N/A
ROA(3y)-42.71%
ROA(5y)-50.69%
ROE(3y)-59.91%
ROE(5y)-86.78%
ROIC(3y)N/A
ROIC(5y)N/A
EQ Yearly ROA, ROE, ROICEQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100 -100 -150

1.3 Margins

  • EQ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EQ Yearly Profit, Operating, Gross MarginsEQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. EQ Health Analysis

2.1 Basic Checks

  • EQ does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, EQ has more shares outstanding
  • EQ has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for EQ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EQ Yearly Shares OutstandingEQ Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
EQ Yearly Total Debt VS Total AssetsEQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • EQ has an Altman-Z score of 12.76. This indicates that EQ is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of EQ (12.76) is better than 83.33% of its industry peers.
  • There is no outstanding debt for EQ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 12.76
ROIC/WACCN/A
WACC9.46%
EQ Yearly LT Debt VS Equity VS FCFEQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 10.58 indicates that EQ has no problem at all paying its short term obligations.
  • The Current ratio of EQ (10.58) is better than 81.98% of its industry peers.
  • EQ has a Quick Ratio of 10.58. This indicates that EQ is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of EQ (10.58) is better than 81.98% of its industry peers.
Industry RankSector Rank
Current Ratio 10.58
Quick Ratio 10.58
EQ Yearly Current Assets VS Current LiabilitesEQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. EQ Growth Analysis

3.1 Past

  • The earnings per share for EQ have decreased strongly by -117.39% in the last year.
  • EQ shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
EPS 1Y (TTM)-117.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • The Earnings Per Share is expected to grow by 4.36% on average over the next years.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y59.83%
EPS Next 2Y22.7%
EPS Next 3Y8.55%
EPS Next 5Y4.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EQ Yearly Revenue VS EstimatesEQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 10M 20M 30M 40M
EQ Yearly EPS VS EstimatesEQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. EQ Valuation Analysis

4.1 Price/Earnings Ratio

  • EQ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year EQ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EQ Price Earnings VS Forward Price EarningsEQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EQ Per share dataEQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.7%
EPS Next 3Y8.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EQ Dividend Analysis

5.1 Amount

  • No dividends for EQ!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EQ Fundamentals: All Metrics, Ratios and Statistics

EQUILLIUM INC

NASDAQ:EQ (4/20/2026, 2:32:32 PM)

1.95

-0.1 (-4.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-25
Earnings (Next)05-12
Inst Owners60.87%
Inst Owner Change0%
Ins Owners13.49%
Ins Owner Change-2.19%
Market Cap123.30M
Revenue(TTM)N/A
Net Income(TTM)-22.40M
Analysts85
Price Target7.91 (305.64%)
Short Float %5.41%
Short Ratio5.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)47.55%
Min EPS beat(2)35.28%
Max EPS beat(2)59.83%
EPS beat(4)4
Avg EPS beat(4)35.39%
Min EPS beat(4)16.03%
Max EPS beat(4)59.83%
EPS beat(8)8
Avg EPS beat(8)55.66%
EPS beat(12)12
Avg EPS beat(12)53.75%
EPS beat(16)14
Avg EPS beat(16)64.22%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)210%
PT rev (3m)210%
EPS NQ rev (1m)37.14%
EPS NQ rev (3m)12%
EPS NY rev (1m)30.36%
EPS NY rev (3m)18.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.31
P/tB 4.31
EV/EBITDA N/A
EPS(TTM)-0.5
EYN/A
EPS(NY)-0.2
Fwd EYN/A
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS0
BVpS0.45
TBVpS0.45
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -70.24%
ROE -78.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-42.71%
ROA(5y)-50.69%
ROE(3y)-59.91%
ROE(5y)-86.78%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 41.38%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.58
Quick Ratio 10.58
Altman-Z 12.76
F-Score2
WACC9.46%
ROIC/WACCN/A
Cap/Depr(3y)47.7%
Cap/Depr(5y)92.43%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-117.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y59.83%
EPS Next 2Y22.7%
EPS Next 3Y8.55%
EPS Next 5Y4.36%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-185.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-19.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.55%
OCF growth 3YN/A
OCF growth 5YN/A

EQUILLIUM INC / EQ Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EQUILLIUM INC?

ChartMill assigns a fundamental rating of 2 / 10 to EQ.


Can you provide the valuation status for EQUILLIUM INC?

ChartMill assigns a valuation rating of 0 / 10 to EQUILLIUM INC (EQ). This can be considered as Overvalued.


How profitable is EQUILLIUM INC (EQ) stock?

EQUILLIUM INC (EQ) has a profitability rating of 0 / 10.


How financially healthy is EQUILLIUM INC?

The financial health rating of EQUILLIUM INC (EQ) is 8 / 10.